Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
43.80    0.00 (0.00%)
Bid:
42.80
Ask:
44.80
Spread: 2.00 (4.673%)
Market Cap: £68.37m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Interim Management Statement

17 Oct 2008 14:14

RNS Number : 1250G
Aberdeen Growth Opps VCT PLC
17 October 2008
 



Aberdeen Growth Opportunities VCT PLC 

Interim Management Statement 

1. Net Asset Value

Ordinary share net asset value (NAV) of 90.65p at 31 August 2008 (97.8p at 31 May 2008)

C Ordinary share net asset value (NAV) of 97.6p at 31 August 2008 (99.2p at 31 May 2008)

The NAVs shown above are unaudited and reflect the closing bid prices of quoted securities at 31 August 2008. Unlisted companies are normally valued on a six-monthly basis and the NAVs include the Directors' valuations of unlisted investments as at 31 May 2008 adjusted for material developments within the portfolios since that date.  

2. Investments and disposals

For the Ordinary share portfolio, during the quarter ended 31 August 2008, investments totalling £498,000 were made in six unlisted or AIM/PLUS quoted companies. During the same period, a combination of partial and complete disposals of five unlisted or AIM quoted investments generated aggregate proceeds of £486,400 against cost of £309,138.

For the C share portfolio, during the quarter ended 31 August 2008, investments totalling £698,000 were made in four unlisted or AIM/PLUS quoted companies. During the same period, a combination of partial and complete disposals of four unlisted or AIM quoted investments generated aggregate proceeds of £620,246 against cost of £380,289.

There were no other material transactions during the period under review. 

3. Recent developments 

No further investments have been made since 31 August 2008.

Since that date, a partial disposal of one investment from the Ordinary share portfolio generated proceeds of £1,516,000 against cost of £884,000 and a partial disposal of one investment from the C share portfolio, generated proceeds of £2,329,000 against cost of £1,359,000.

Being invested mainly in unlisted companies, the portfolio is to some degree protected from the current volatility of stock markets. However, the recent, dramatic fall in the value of stocks quoted on AIM has reduced the NAV of the Ordinary Shares by 8p and that of the C Shares by 5p as at close of business on 16 October. The Board is not aware of any other events or transactions that have taken place between 31 August 2008 and the date of publication of this statement that have had a material impact on the financial position of the Company.

Issued on behalf of the Board

Aberdeen Asset Management PLC, Secretary

17 October 2008

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGUGUGUUPRGWM
Date   Source Headline
11th Mar 202211:35 amRNSIssue of Equity - Dividend Investment Scheme
10th Mar 202211:30 amRNSIssue of Equity
10th Mar 202211:20 amRNSStatement re Dividend Investment Scheme
7th Mar 20226:32 pmRNSAnnual Financial Report
22nd Feb 20222:27 pmRNSTransaction in Own Shares
18th Feb 20225:48 pmRNSIssue of Equity - Replacement Announcement
7th Feb 20221:53 pmRNSDirector/PDMR Shareholding
7th Feb 20221:52 pmRNSDirector/PDMR Shareholding
7th Feb 20221:50 pmRNSDirector/PDMR Shareholding
7th Feb 20221:48 pmRNSDirector/PDMR Shareholding
7th Feb 20221:47 pmRNSDirector/PDMR Shareholding
7th Feb 20221:46 pmRNSDirector/PDMR Shareholding
7th Feb 202210:50 amRNSIssue of Equity
4th Feb 20229:45 amRNSStatement re NAV and Final Dividend
31st Jan 20224:25 pmRNSStatement re Offer for Subscription
10th Jan 202212:43 pmRNSStatement re Offer for Subscription
5th Jan 202210:35 amRNSDividend Declaration
24th Nov 20214:45 pmRNSTransaction in Own Shares
29th Oct 202112:44 pmRNSNet Asset Value(s)
20th Oct 20214:46 pmRNSResult of General Meeting
20th Sep 20215:21 pmRNSPublication of a Prospectus
20th Sep 20214:57 pmRNSStatement re Change of Registrar
10th Sep 202112:34 pmRNSIssue of Equity
7th Sep 20213:08 pmRNSStatement re Dividend Investment Scheme
16th Aug 20214:08 pmRNSTransaction in Own Shares
13th Aug 20212:13 pmRNSHalf-year Report
5th Aug 20214:39 pmRNSTransaction in Own Shares
3rd Aug 202111:31 amRNSStatement re NAV and Interim Dividend
16th Jun 20213:16 pmRNSStatement re Offer for Subscription
16th Apr 202110:25 amRNSIssue of Equity
15th Apr 20214:30 pmRNSTransaction in Own Shares
13th Apr 20212:22 pmRNSStatement re Dividend Investment Scheme
12th Apr 20219:00 amRNSNet Asset Value(s)
7th Apr 202112:28 pmRNSResult of AGM
5th Mar 20214:39 pmRNSFinal Results
29th Jan 20212:55 pmRNSTransaction in Own Shares
22nd Jan 20213:17 pmRNSNAV and Proposed Final Dividend
17th Nov 20204:29 pmRNSTransaction in Own Shares
16th Nov 20204:55 pmRNSTransaction in Own Shares
11th Nov 20204:58 pmRNSNet Asset Value(s)
28th Aug 202010:28 amRNSIssue of Equity
26th Aug 20205:23 pmRNSTransaction in Own Shares
21st Aug 20204:10 pmRNSStatement re NAV and DIS
29th Jul 20204:45 pmRNSTransaction in Own Shares
28th Jul 20204:44 pmRNSTransaction in Own Shares
24th Jul 20203:23 pmRNSHalf-year Report
9th Jul 202010:00 amRNSIssue of Equity
29th Jun 20205:25 pmRNSStatement re NAV and Interim Dividend
8th Jun 20209:33 amRNSAllotment Update
15th May 20204:55 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.